Avocado Consumption and Cellular Aging in Breast Cancer Survivors
NCT07097155 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-05-12
Summary
Women with breast cancer are at increased risk of comorbidities and premature mortality, potentially due to accelerated biological aging. Telomere attrition has been proposed as a biomarker of this process, which could be mitigated through interventions targeting behavioral factors such as diet. In recent years, avocado has drawn attention in nutritional research due to its unique nutritional profile.
Main objective: To evaluate the effect of consuming one avocado per day on biological aging-measured by telomere length-in breast cancer survivors, compared to a habitual diet (less than two avocados per week). Secondary objectives include changes in telomerase activity and biomarkers of inflammation and oxidative stress. Additional objectives include classical cardiovascular disease markers (glucose metabolism, lipid profile, blood pressure); anthropometric measurements; symptoms of depression and anxiety; quality of life and fatigue; and diet quality.
Methodology: A randomized controlled parallel-group trial involving 120 breast cancer survivors. Participants will be randomly assigned to either the intervention group (one avocado per day) or the control group (habitual diet with fewer than two avocados per week) and followed for 4 months. At baseline and the end of the intervention, a general questionnaire will be administered; blood and urine samples will be collected; anthropometric and blood pressure measurements will be taken; and diet, physical activity, symptoms of depression and anxiety, quality of life, and fatigue will be assessed. Mean changes from baseline to the end of the intervention in the primary outcome (telomere length) and secondary outcomes (inflammation, oxidative stress, classical cardiovascular disease markers, anthropometric measures, symptoms of depression and anxiety, quality of life, and diet) will be compared between the intervention and control groups using linear regression models.
Conditions
- Telomere Length
- Breast Cancer Females
Interventions
- OTHER
-
Daily Avocado Consumption
Participants follow their usual diet and consume one avocado per day for 4 months
Sponsors & Collaborators
-
Institut Investigacio Sanitaria Pere Virgili
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-12
- Primary Completion
- 2027-03-31
- Completion
- 2027-08-31
Countries
- Spain
Study Locations
More Related Trials
-
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
NCT00691509 ·Status: UNKNOWN
-
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
NCT00078832 ·Status: COMPLETED ·Phase: PHASE3
-
Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
NCT00055991 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
NCT01384526 ·Status: COMPLETED
-
Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer
NCT00816244 ·Status: COMPLETED ·Phase: PHASE2
-
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
NCT01219075 ·Status: COMPLETED ·Phase: NA
-
Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer
NCT00301457 ·Status: COMPLETED ·Phase: PHASE3
-
Antioxidant Supplements, Genetics and Chemotherapy Outcomes
NCT03413761 ·Status: COMPLETED
-
The Role of Diet and Lifestyle in Breast Cancer Survival
NCT00701584 ·Status: UNKNOWN
-
Oocyte Recovery During Tamoxifen Adjuvant Therapy
NCT02355600 ·Status: UNKNOWN
-
Tamoxifen in Treating Women With Breast Cancer
NCT00003678 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
NCT01080170 ·Status: COMPLETED
-
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
NCT02831582 ·Status: COMPLETED ·Phase: NA
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT05941520 ·Status: RECRUITING ·Phase: PHASE2
-
Mediterranean Diet and Inequality in Early Breast Cancer
NCT07007169 ·Status: RECRUITING ·Phase: PHASE2
-
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
NCT00090844 ·Status: TERMINATED ·Phase: PHASE2
-
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT00003771 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
NCT00068328 ·Status: COMPLETED
-
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
NCT00096369 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Short-term Fasting on Tolerance to Chemotherapy
NCT01304251 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer
NCT05975437 ·Status: ENROLLING_BY_INVITATION
-
Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors
NCT06214598 ·Status: RECRUITING ·Phase: NA
-
Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
NCT07273357 ·Status: NOT_YET_RECRUITING
-
Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer
NCT03946579 ·Status: COMPLETED ·Phase: NA